The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
10915041 |
2 |
Synthesis of fluorescent probes directed to the active site gorge of acetylcholinesterase. |
The University Of Montana |
27908752 |
55 |
N-Propargylpiperidines with naphthalene-2-carboxamide or naphthalene-2-sulfonamide moieties: Potential multifunctional anti-Alzheimer's agents. |
University Of Ljubljana |
27448914 |
30 |
Ameliorative effects of amide derivatives of 1,3,4-thiadiazoles on scopolamine induced cognitive dysfunction. |
University Institute Of Pharmaceutical Sciences |
27598521 |
22 |
Discovery of Selective Inhibitors Targeting Acetylcholinesterase 1 from Disease-Transmitting Mosquitoes. |
Ume£ |
26116179 |
5 |
Structure-based development of nitroxoline derivatives as potential multifunctional anti-Alzheimer agents. |
University Of Ljubljana |
25468034 |
33 |
Synthesis of aminoalkyl-substituted aurone derivatives as acetylcholinesterase inhibitors. |
Kyung Hee University |
25226236 |
19 |
Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor. |
University Of Ljubljana |
24485122 |
9 |
Synthesis of aminoalkyl-substituted coumarin derivatives as acetylcholinesterase inhibitors. |
Kyung Hee University |
23984975 |
29 |
Divergent structure-activity relationships of structurally similar acetylcholinesterase inhibitors. |
Ume£ |
23941108 |
1 |
Casuarinines A-J, lycodine-type alkaloids from Lycopodiastrum casuarinoides. |
Fudan University |
8558505 |
77 |
A comparative molecular field analysis study of N-benzylpiperidines as acetylcholinesterase inhibitors. |
University Of Missouri St. Louis |
23026084 |
17 |
Lead optimization studies towards the discovery of novel carbamates as potent AChE inhibitors for the potential treatment of Alzheimer's disease. |
Csir-Central Drug Research Institute |
18479118 |
114 |
Exploiting protein fluctuations at the active-site gorge of human cholinesterases: further optimization of the design strategy to develop extremely potent inhibitors. |
Universit£ |
18333606 |
29 |
Bis-(-)-nor-meptazinols as novel nanomolar cholinesterase inhibitors with high inhibitory potency on amyloid-beta aggregation. |
Fudan University |
15214773 |
76 |
Fragment-based drug discovery. |
Sunesis Pharmaceuticals |
7490731 |
45 |
Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine hydrochloride and related compounds. |
Eisai |
1552502 |
74 |
Synthesis and cholinergic properties of bis[[(dimethylamino)methyl]furanyl] analogues of ranitidine. |
University Of South Carolina |
18438404 |
13 |
Activation of the endocannabinoid system by organophosphorus nerve agents. |
University Of California |
20137941 |
44 |
Design, synthesis and evaluation of carbamate-modified (-)-N(1)-phenethylnorphysostigmine derivatives as selective butyrylcholinesterase inhibitors. |
Kyoto University |
20137934 |
38 |
Design, synthesis, evaluation and QSAR analysis of N(1)-substituted norcymserine derivatives as selective butyrylcholinesterase inhibitors. |
Kyoto University |
| 27 |
Synthesis and anti-acetylcholinesterase activity of 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine hydrochloride (E2020) and related compounds |
TBA |
8709135 |
20 |
Identification of a 3-hydroxylated tacrine metabolite in rat and man: metabolic profiling implications and pharmacology. |
Warner-Lambert |
8027982 |
19 |
Syntheses and anticholinesterase activity of tetrahydrobenzazepine carbamates. |
Pfizer |
1469686 |
53 |
Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-(2-phthalimidoethyl)piperidine and related derivatives. |
Eisai |
20846091 |
3 |
A FLT3-inhibitory constituent from the rhizomes of Anemarrhena asphodeloides. |
Gyeongsang National University |
14718605 |
8 |
Identification and characterization of 4-[[4-(2-butynyloxy)phenyl]sulfonyl]-N-hydroxy-2,2-dimethyl-(3S)thiomorpholinecarboxamide (TMI-1), a novel dual tumor necrosis factor-alpha-converting enzyme/matrix metalloprotease inhibitor for the treatment of rheumatoid arthritis. |
Wyeth Research |